Related Articles
Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection
DIAGNOSTIC USEFULNESS OF 5 TUMOR-MARKERS IN PATIENTS WITH PRIMARY LUNG-CANCER
PROSPECTIVE MULTICENTER STUDY ON THE CLINICAL UTILITY OF CA-72.4 IN POSTMENOPAUSAL PATIENTS WITH PELVIC MASS
Individual variations of total and percent free serum prostatic specific antigen: could they change the indication of prostatic biopsy?